Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Lara Bapir, Simon Erridge, Martha Nicholas, Manaswini Pillai, Nishaanth Dalavaye, Carl Holvey, Ross Coomber, Jonathan Hoare, Shaheen Khan, Mark W Weatherall, James J Rucker, Michael Platt & Mikael H Sodergren. (2023) Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study. Expert Review of Neurotherapeutics 23:3, pages 281-295.
Read now
Read now
Michael A Ueberall, Ute Essner, Carlos Vila Silván & Gerhard H H Mueller-Schwefe. (2022) Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry. Journal of Pain Research 15, pages 267-286.
Read now
Read now
José María Prieto González & Carlos Vila Silván. (2021) Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports. Expert Review of Neurotherapeutics 21:5, pages 547-558.
Read now
Read now
Michael A Überall. (2020) A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain. Journal of Pain Research 13, pages 399-410.
Read now
Read now
Articles from other publishers (29)
Elise A Schubert, Masego T Johnstone, Melissa J Benson, Johannes C Alffenaar & Nial J Wheate. (2022) Medicinal cannabis for Australian patients with chronic refractory pain including arthritis. British Journal of Pain 17:2, pages 206-217.
Crossref
Crossref
George Jîtcă, Bianca E. Ősz, Camil E. Vari, Carmen-Maria Rusz, Amelia Tero-Vescan & Amalia Pușcaș. (2023) Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance. Antioxidants 12:2, pages 485.
Crossref
Crossref
Tina Horsted, Karoline Lichon Hesthaven & Peter Derek Christian Leutscher. (2022) Safety and effectiveness of cannabinoids to Danish patients with treatment refractory chronic pain—A retrospective observational real‐world study. European Journal of Pain 27:2, pages 234-247.
Crossref
Crossref
Stevie C. Britch & Rebecca M. Craft. (2023) Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain. The Journal of Pain 24:1, pages 98-111.
Crossref
Crossref
Antonio ViganoYola MorideYasmina Hachem, Michelle Canac-MarquisRihab GamaounMaja Kalaba, Marc O. MartelJordi PerezAndrée NéronPierre BeaulieuJulie DesrochesMark Ware. (2022) The Quebec Cannabis Registry: Investigating the Safety and Effectiveness of Medical Cannabis. Cannabis and Cannabinoid Research.
Crossref
Crossref
Ralph-Sydney Mboumba Bouassa, Judy Needham, Dana Nohynek, Joel Singer, Terry Lee, Florian Bobeuf, Suzanne Samarani, Lina Del Balso, Natalie Paisible, Claude Vertzagias, Giada Sebastiani, Shari Margolese, Enrico Mandarino, Marina Klein, Bertrand Lebouché, Joseph Cox, Marie-Josée Brouillette, Jean-Pierre Routy, Jason Szabo, Réjean Thomas, Emmanuel Huchet, Antonio Vigano, Mohammad-Ali Jenabian & Cecilia T Costiniuk. (2022) Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028). Biomedicines 10:12, pages 3168.
Crossref
Crossref
Riccardo Giossi, Federica Carrara, Matteo Padroni, Maria Concetta Bilancio, Martina Mazzari, Silvia Enisci, Maria Silvia Romio, Gloria Boni, Federica Corrù, Veronica Andrea Fittipaldo, Irene Tramacere, Arianna Pani, Francesco Scaglione & Diego Fornasari. (2022) Systematic Review and Meta-analysis Seem to Indicate that Cannabinoids for Chronic Primary Pain Treatment Have Limited Benefit. Pain and Therapy 11:4, pages 1341-1358.
Crossref
Crossref
Anne Katrin Schlag, Rayyan R. Zafar, Michael T. Lynskey, Alkyoni Athanasiou-Fragkouli, Lawrence D. Phillips & David J. Nutt. (2022) The value of real world evidence: The case of medical cannabis. Frontiers in Psychiatry 13.
Crossref
Crossref
Dena Zeraatkar, Matthew Adam Cooper, Arnav Agarwal, Robin W M Vernooij, Gareth Leung, Kevin Loniewski, Jared E Dookie, Muhammad Muneeb Ahmed, Brian Y Hong, Chris Hong, Patrick Hong, Rachel Couban, Thomas Agoritsas & Jason W Busse. (2022) Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies. BMJ Open 12:8, pages e054282.
Crossref
Crossref
Jeremy D. Henson, Luis Vitetta & Sean Hall. (2022) Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions. Inflammopharmacology 30:4, pages 1167-1178.
Crossref
Crossref
Victor Mayoral. (2022) An overview of the use and misuse/abuse of opioid analgesics in different world regions and future perspectives. Pain Management 12:4, pages 535-555.
Crossref
Crossref
Michael A UeberallMDMD, Carlos Vila SilvánMDMD, Ute Essner & Gerhard H H Mueller-SchwefeMDMD. (2022) Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry. Pain Medicine 23:4, pages 745-760.
Crossref
Crossref
Rishi Banerjee, Simon Erridge, Oliver Salazar, Nagina Mangal, Daniel Couch, Barbara Pacchetti & Mikael Hans Sodergren. (2021) Real World Evidence in Medical Cannabis Research. Therapeutic Innovation & Regulatory Science 56:1, pages 8-14.
Crossref
Crossref
Frank Petzke, Thomas Tölle, Mary-Ann Fitzcharles & Winfried Häuser. (2021) Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain. CNS Drugs 36:1, pages 31-44.
Crossref
Crossref
L.K. Friedman, H. Peng & R.J. Zeman. (2021) Cannabidiol reduces lesion volume and restores vestibulomotor and cognitive function following moderately severe traumatic brain injury. Experimental Neurology 346, pages 113844.
Crossref
Crossref
Michal Kawka, Simon Erridge, Carl Holvey, Ross Coomber, Azfer Usmani, Mohammad Sajad, Michael W. Platt, James J. Rucker & Mikael H. Sodergren. (2021) Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis‐Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry. The Journal of Clinical Pharmacology 61:12, pages 1545-1554.
Crossref
Crossref
Raquel Maria P. Campos, Andrey F. L. Aguiar, Yolanda Paes-Colli, Priscila Martins Pinheiro Trindade, Bruna K. Ferreira, Ricardo A. de Melo Reis & Luzia S. Sampaio. (2021) Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment. Frontiers in Physiology 12.
Crossref
Crossref
Mathew P Caputo, Carmen S Rodriguez, Tapan A Padhya & Matthew J Mifsud. (2021) Medical Cannabis as Adjunctive Therapy for Head and Neck Cancer Patients. Cureus.
Crossref
Crossref
Brooke Porter, Barbara St. Marie, Gary Milavetz & Keela Herr. (2021) Cannabidiol (CBD) Use by Older Adults for Acute and Chronic Pain. Journal of Gerontological Nursing 47:7, pages 6-15.
Crossref
Crossref
Carmen Krewer, Dominik Vogel, Veronika Probst & Klaus Jahn. (2021) Medizinisches Cannabis bei neuropathischem Schmerz. Der Schmerzpatient 4:03, pages 120-125.
Crossref
Crossref
Michael Schäfer & Sascha Tafelski. (2021) Cannabis und Cannabinoide zur Therapie akuter und chronischer SchmerzenCannabis and cannabinoids for the treatment of acute and chronic pain. Der Anaesthesist 70:7, pages 551-562.
Crossref
Crossref
Anne Katrin Schlag, Saoirse E. O'Sullivan, Rayyan R. Zafar & David J. Nutt. (2021) Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics. Neuropharmacology 191, pages 108586.
Crossref
Crossref
Shaina P. Cahill, Stephanie E. Lunn, Patrick Diaz & Jonathan E. Page. (2021) Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada. Frontiers in Public Health 9.
Crossref
Crossref
Igor Dykukha, Rolf Malessa, Ute Essner & Michael A Überall. (2021) Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials. Pain Medicine 22:4, pages 861-874.
Crossref
Crossref
Myfanwy Graham, Catherine J. Lucas, Jennifer Schneider, Jennifer H. Martin & Wayne Hall. (2020) Translational hurdles with cannabis medicines. Pharmacoepidemiology and Drug Safety 29:10, pages 1325-1330.
Crossref
Crossref
Anne Katrin Schlag, David S Baldwin, Michael Barnes, Steve Bazire, Rachel Coathup, H Valerie Curran, Rupert McShane, Lawrence D Phillips, Ilina Singh & David J Nutt. (2020) Medical cannabis in the UK: From principle to practice. Journal of Psychopharmacology 34:9, pages 931-937.
Crossref
Crossref
David Nutt, Steve Bazire, Lawrence D Phillips & Anne Katrin Schlag. (2020) So near yet so far: why won’t the UK prescribe medical cannabis?. BMJ Open 10:9, pages e038687.
Crossref
Crossref
Donovan A. Argueta, Christopher M. Ventura, Stacy Kiven, Varun Sagi & Kalpna Gupta. (2020) A Balanced Approach for Cannabidiol Use in Chronic Pain. Frontiers in Pharmacology 11.
Crossref
Crossref
Alejandra Escudero-Lara, Josep Argerich, David Cabañero & Rafael Maldonado. (2020) Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis-associated pain. eLife 9.
Crossref
Crossref